Page last updated: 2024-09-05

cgp 54626 and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

cgp 54626 has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 2 studies

Compound Research Comparison

Studies
(cgp 54626)
Trials
(cgp 54626)
Recent Studies (post-2010)
(cgp 54626)
Studies
(2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline)
Trials
(2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline)
Recent Studies (post-2010) (2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline)
570161,2160229

Protein Interaction Comparison

ProteinTaxonomycgp 54626 (IC50)2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline (IC50)
Glutamate receptor 1Rattus norvegicus (Norway rat)0.5781
Glutamate receptor 2Rattus norvegicus (Norway rat)0.5781
Glutamate receptor 3Rattus norvegicus (Norway rat)0.5781
Glutamate receptor 4Rattus norvegicus (Norway rat)0.5781
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)2.909
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)2.909
Glutamate receptor 1Homo sapiens (human)6
Glutamate receptor 2Homo sapiens (human)2.5
Glutamate receptor 3Homo sapiens (human)1.9
Glutamate receptor ionotropic, kainate 3Rattus norvegicus (Norway rat)2.909
Glutamate receptor 4Homo sapiens (human)1.1
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, kainate 4Rattus norvegicus (Norway rat)2.909
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, kainate 5Rattus norvegicus (Norway rat)2.909
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)0.2
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)0.2

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chavis, P; Farrugia, F; Garenne, A; Le Masson, G; Manzoni, OJ; Marsicano, G; Piet, R1
He, M; Huang, ZJ; Pfeffer, CK; Scanziani, M; Xue, M1

Other Studies

2 other study(ies) available for cgp 54626 and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

ArticleYear
State-dependent, bidirectional modulation of neural network activity by endocannabinoids.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, Nov-16, Volume: 31, Issue:46

    Topics: 4-Aminopyridine; Action Potentials; Animals; Animals, Newborn; Benzothiadiazines; Brain; Cannabinoid Receptor Modulators; Cells, Cultured; Electric Stimulation; Endocannabinoids; Excitatory Amino Acid Antagonists; GABA Antagonists; In Vitro Techniques; Mice; Mice, Transgenic; Nerve Net; Neural Inhibition; Neurons; Organophosphorus Compounds; Picrotoxin; Piperidines; Potassium Channel Blockers; Pyrazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Sodium Channel Blockers; Tetrodotoxin; Valine

2011
Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons.
    Nature neuroscience, 2013, Volume: 16, Issue:8

    Topics: Animals; Biomarkers; Channelrhodopsins; Female; Genes, Reporter; Inhibitory Postsynaptic Potentials; Interneurons; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Tissue Proteins; Neural Inhibition; Optogenetics; Organophosphorus Compounds; Parvalbumins; Patch-Clamp Techniques; Photic Stimulation; Principal Component Analysis; Pyramidal Cells; Quinoxalines; Recombinant Fusion Proteins; Somatostatin; Synaptic Transmission; Vasoactive Intestinal Peptide; Visual Cortex

2013